Carter Bankshares, Inc. (CARE)

Every figure this model derived for CARE, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 8,500,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 276,535,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
equity 539,146,000 StockholdersEquity 2026-06-30
interest expense 95,721,000 InterestPaidNet 2026-06-30
ocf 67,256,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 20,315,000 RevenueFromContractWithCustomerExcludingAssessedTax 2025-12-31
sbc 2,196,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CARE on one particular measure came for.

RatioValue
dilution pct-1.58
fcf margin289.22
growth cv2.41
owner earnings margin278.41
revenue growth4.65
revenue growth per share6.33
sbc pct revenue10.81

What to be careful about

What this model itself distrusts about CARE's figures. Written by the derivation as it ran, not added afterwards.